Michael A Zimmerman

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado Denver, Denver, CO 80045, USA
    Liver Transpl 19:259-67. 2013
  2. doi request reprint The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado at Denver and Health Sciences Center, Department of Anesthesia, Aurora, CO 800451, USA
    Clin Transplant 24:E103-8. 2010
  3. pmc Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus
    Michael A Zimmerman
    Division of Pulmonary Sciences and Critical Care Medicine, Colorado Center for Transplantation Care, Research and Education, Denver, Colorado, USA
    J Surg Res 168:e195-202. 2011
  4. doi request reprint Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO 80045, USA
    Liver Transpl 14:633-8. 2008
  5. doi request reprint Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO 80045, USA
    Liver Transpl 14:1281-6. 2008
  6. ncbi request reprint Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Transpl Int 20:747-53. 2007
  7. doi request reprint Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 14:181-5. 2008
  8. doi request reprint Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation
    William Bennet
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Campus Box C 318, 7th Floor 1675 Aurora Court, Aurora, CO 80045, USA
    World J Surg 33:1022-5. 2009
  9. pmc Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion
    Michael A Zimmerman
    Division of Transplant Surgery, Department of Surgery, University of Colorado, Aurora, CO
    Hepatology 58:1766-78. 2013
  10. doi request reprint Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Transplantation 85:775-7. 2008

Collaborators

Detail Information

Publications21

  1. pmc Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado Denver, Denver, CO 80045, USA
    Liver Transpl 19:259-67. 2013
    ..61). Although the incidence of biliary complications is higher after LDLT versus DDLT, the treatment requirements and the time to resolution after the development of a biliary complication are similar for LDLT and DDLT recipients...
  2. doi request reprint The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado at Denver and Health Sciences Center, Department of Anesthesia, Aurora, CO 800451, USA
    Clin Transplant 24:E103-8. 2010
    ..Recent evidence suggests that anti-CD3 antibody (OKT3) therapy may be associated with increased rates of HCC recurrence...
  3. pmc Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus
    Michael A Zimmerman
    Division of Pulmonary Sciences and Critical Care Medicine, Colorado Center for Transplantation Care, Research and Education, Denver, Colorado, USA
    J Surg Res 168:e195-202. 2011
    ..We hypothesize that an alteration in T lymphocyte homeostasis may result in early vascular inflammation, which might amplify subsequent blood vessel injury in euglycemia...
  4. doi request reprint Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO 80045, USA
    Liver Transpl 14:633-8. 2008
    ..Cumulatively, these data suggest a potential survival benefit with SRL-based therapy in patients undergoing OLT for end-stage liver disease and concomitant malignancy...
  5. doi request reprint Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO 80045, USA
    Liver Transpl 14:1281-6. 2008
    ..In conclusion, outcomes in AIH patients were quite favorable, and none of the patients required retransplantation for recurrent AIH. With a CS minimization approach, one-half of the patients were able to remain CS-free...
  6. ncbi request reprint Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Transpl Int 20:747-53. 2007
    ..Pathologic variables including tumor stage and grade have a significant impact on outcome. Importantly, it seems that TACE and sirolimus had no beneficial effect...
  7. doi request reprint Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, CO, USA
    Liver Transpl 14:181-5. 2008
    ..6-50.6 months). In conclusion, recurrent PSC following OLT is a formidable but protracted problem following OLT. Patients may require a second transplant following reemergent disease with reasonable survival benefit...
  8. doi request reprint Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation
    William Bennet
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Campus Box C 318, 7th Floor 1675 Aurora Court, Aurora, CO 80045, USA
    World J Surg 33:1022-5. 2009
    ..We provide preliminary evidence that CDD is a safe technique for biliary anastomosis in liver transplant recipients...
  9. pmc Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion
    Michael A Zimmerman
    Division of Transplant Surgery, Department of Surgery, University of Colorado, Aurora, CO
    Hepatology 58:1766-78. 2013
    ..Conclusion: These findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury...
  10. doi request reprint Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Transplantation 85:775-7. 2008
    ..This approach allows adequate venous outflow through the right hepatic vein more than 1 cm, which is demonstrated by the absence of graft loss from venous congestion and superior graft survival...
  11. doi request reprint Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation
    Jeffrey Campsen
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Aurora, CO, USA
    Transplantation 87:1842-5. 2009
    ..We provide the first evidence that HD is an alternative technique for biliary reconstruction in LDLT...
  12. ncbi request reprint Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma
    Jeffrey Campsen
    University of Colorado Health Sciences Center, Division of Transplant Surgery, Denver, CO 80262, USA
    Expert Opin Pharmacother 8:1275-82. 2007
    ..Herein, the authors review the experience to date with SRL as a primary immunosuppressive agent following OLT, and discuss the clinical implications of SRL-based therapy in OLT recipients with cirrhosis and cancer...
  13. doi request reprint Choledochoduodenostomy in pediatric liver transplantation
    Jeffrey Campsen
    Department of Surgery, Division of Transplant Surgery, University of Colorado Denver School of Medicine, Aurora, CO, USA
    Pediatr Transplant 15:237-9. 2011
    ..We provide preliminary evidence that CDD is an alternative technique for biliary reconstruction when CC is not possible in pediatric liver transplant recipients that have a hostile abdomen or to preserve bowel length...
  14. pmc Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation
    Alexander B Benson
    Division of Pulmonary Sciences and Critical Care, University of Colorado, Aurora, CO 80045, USA
    Liver Transpl 17:149-58. 2011
    ..Plasma-containing blood products were associated with the development of TRALI, whereas red blood cells were associated with the development of postoperative infections in a dose-dependent manner...
  15. pmc Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver
    Michael A Zimmerman
    Division of Transplant Surgery, Department of Surgery, and Mucosal Inflammation Program, Department of Anesthesiology, University of Colorado, Denver, Aurora, CO 80045, USA
    Proc Natl Acad Sci U S A 110:12012-7. 2013
    ..These studies provide a unique role for hepatocellular-specific Adora2b signaling in liver protection during ischemia and reperfusion injury...
  16. pmc A Decade of Experience Using mTor Inhibitors in Liver Transplantation
    Jeffrey Campsen
    Division of Transplant Surgery, Department of Surgery, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    J Transplant 2011:913094. 2011
    ..There were no significant differences in mortality or graft loss. There was no difference in patient or graft survival. Patients that received SRL as primary immunosuppression had 50% less rejection compared to controls...
  17. pmc Donor complications following laparoscopic compared to hand-assisted living donor nephrectomy: an analysis of the literature
    Whitney R Halgrimson
    Division of Transplant Surgery, University of Colorado Health Sciences Center, P O Box 6510, Aurora, CO 80045I, USA
    J Transplant 2010:825689. 2010
    ..There are trends in the data suggesting that intraoperative injuries are more common in LDN while minor postoperative complications are more common in HALDN...
  18. pmc Protective role for netrin-1 during diabetic nephropathy
    Eunyoung Tak
    Department of Anesthesiology, University of Colorado Denver, Anschutz Medical Campus, 12700 E 19th Avenue, Mailstop B112, Research Complex 2, Room 7121, Aurora, CO 80045, USA
    J Mol Med (Berl) 91:1071-80. 2013
    ..Taken together, these studies demonstrate a functional role for endogenous netrin-1 in attenuating diabetic kidney disease...
  19. ncbi request reprint Living donor liver transplantation in patients with hepatitis C
    Michael A Zimmerman
    Division of Gastroenterology Hepatology, University of Colorado Health Sciences Center, Denver, CO 80202, USA
    Liver Transpl 9:S52-7. 2003
    ..3. Potential mechanisms for differences in severity of HCV in LDLT recipients are discussed. 4. LDLT remains a viable treatment option for selected patients with HCV...
  20. doi request reprint Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes
    Michael A Zimmerman
    Division of Transplant Surgery, University of Colorado Health Sciences Center, Aurora, Colorado 80262, USA
    J Surg Res 155:173-8. 2009
    ....
  21. pmc A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection
    John A Mengshol
    Department of Medicine, Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America
    PLoS ONE 5:e9504. 2010
    ..In conclusion, galectin-9 production by Kupffer cells links the innate and adaptive immune response, providing a potential novel immunotherapeutic target in this common viral infection...